Medical Cannabis and Cannabinoids

Skip Nav Destination

Medical Cannabis and Cannabinoids 2022, Vol. 5, No. 1

Case Report

Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases

Subject Area: General Medicine , Pharmacology , Public Health

Holly Mansell; Declan Quinn; Lauren E. Kelly; Jane Alcorn

Med Cannabis Cannabinoids (2022) 5 (1): 1–6. https://doi.org/10.1159/000521370

Abstract

View articletitled, Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases

Open the PDF for in another window

Cannabinoids as Cocrystals

Subject Area: General Medicine , Pharmacology , Public Health

Crist N. Filer

Med Cannabis Cannabinoids (2022) 5 (1): 7–8. https://doi.org/10.1159/000521137

View articletitled, Cannabinoids as Cocrystals

Open the PDF for in another window

A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery

Subject Area: General Medicine , Pharmacology , Public Health

Stefan Lorenzl; Franz Gottwald; Angelika Nistler; Laura Brehm; Renate Grötsch; Georg Haber; Christian Bremm; Christiane Weck; Carina Trummer; Werner Brand

Med Cannabis Cannabinoids (2022) 5 (1): 9–19. https://doi.org/10.1159/000521352

Abstract

View articletitled, A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery

Open the PDF for in another window

Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation

Subject Area: General Medicine , Pharmacology , Public Health

Sarah Abelev; Leon N. Warne; Melissa Benson; Mark Hardy; Sunny Nayee; John Barlow

Med Cannabis Cannabinoids (2022) 5 (1): 20–31. https://doi.org/10.1159/000521492

Abstract

View articletitled, Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation

Open the PDF for in another window

Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?

Subject Area: General Medicine , Pharmacology , Public Health

Joshua D. Brown; Amie J. Goodin

Med Cannabis Cannabinoids (2022) 5 (1): 32–35. https://doi.org/10.1159/000522472

View articletitled, Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?

Open the PDF for in another window

6th International Medical Cannabis Conference (CannX 2022) Tel Aviv, Israel, March 14-15, 2022

Subject Area: General Medicine , Pharmacology , Public Health

Med Cannabis Cannabinoids (2022) 5 (1): 36–60. https://doi.org/10.1159/000522395

View articletitled, 6th International Medical Cannabis Conference (CannX 2022) Tel Aviv, Israel, March 14-15, 2022

Open the PDF for in another window

Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option?

Subject Area: General Medicine , Pharmacology , Public Health

Walter Zieglgänsberger; Rudolf Brenneisen; Achim Berthele; Carsten T. Wotjak; Borwin Bandelow; Thomas R. Tölle; Beat Lutz

Med Cannabis Cannabinoids (2022) 5 (1): 61–75. https://doi.org/10.1159/000522432

Abstract

View articletitled, Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option?

Open the PDF for in another window

The Effects of Consuming Cannabis Flower for Treatment of Fatigue

Subject Area: General Medicine , Pharmacology , Public Health

Xiaoxue Li; Jegason P. Diviant; Sarah S. Stith; Franco Brockelman; Keenan Keeling; Branden Hall; Jacob M. Vigil

Med Cannabis Cannabinoids (2022) 5 (1): 76–84. https://doi.org/10.1159/000524057

Abstract

View articletitled, The Effects of Consuming Cannabis Flower for Treatment of Fatigue

Open the PDF for in another window

Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

Subject Area: General Medicine , Pharmacology , Public Health

Tess Puopolo; Chang Liu; Hang Ma; Navindra P. Seeram

Med Cannabis Cannabinoids (2022) 5 (1): 85–94. https://doi.org/10.1159/000524086

Abstract

View articletitled, Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

Open the PDF for in another window

Clinical Characteristics and Quality of Life in Adults Initiating Medical Marijuana Treatment

Subject Area: General Medicine , Pharmacology , Public Health

Lydia S. Buonomano; Matthew M. Mitnick; Thomas R. McCalmont; Paulina Syracuse; Karen L. Dugosh; David S. Festinger; Michelle R. Lent

Med Cannabis Cannabinoids (2022) 5 (1): 95–101. https://doi.org/10.1159/000524831

Abstract

View articletitled, Clinical Characteristics and Quality of Life in Adults Initiating Medical Marijuana Treatment

Open the PDF for in another window

Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We?

Subject Area: General Medicine , Pharmacology , Public Health

Manikandan Palrasu; Lillianne Wright; Manish Patel; Lindsey Leech; Scotty Branch; Shea Harrelson; Saeed Khan

Med Cannabis Cannabinoids (2022) 5 (1): 102–119. https://doi.org/10.1159/000525629

Abstract

View articletitled, Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We?

Open the PDF for in another window

Clinical Considerations for Cannabis Use and Cardiovascular Health

Subject Area: General Medicine , Pharmacology , Public Health

Ruba Sajdeya; Sebastian Jugl; Robert Cook; Joshua D. Brown; Amie Goodin

Med Cannabis Cannabinoids (2022) 5 (1): 120–127. https://doi.org/10.1159/000526731

View articletitled, Clinical Considerations for Cannabis Use and Cardiovascular Health

Open the PDF for in another window

Erratum

Subject Area: General Medicine , Pharmacology , Public Health

Med Cannabis Cannabinoids (2022) 5 (1): 128. https://doi.org/10.1159/000527071

View articletitled, Erratum

Open the PDF for in another window

Evaluations of Skin Permeability of Cannabidiol and Its Topical Formulations by Skin Membrane-Based Parallel Artificial Membrane Permeability Assay and Franz Cell Diffusion Assay

Subject Area: General Medicine , Pharmacology , Public Health

Riley D. Kirk; Toyosi Akanji; Huifang Li; Jie Shen; Saleh Allababidi; Navindra P. Seeram; Matthew J. Bertin; Hang Ma

Med Cannabis Cannabinoids (2022) 5 (1): 129–137. https://doi.org/10.1159/000526769

Abstract

View articletitled, Evaluations of Skin Permeability of Cannabidiol and Its Topical Formulations by Skin Membrane-Based Parallel Artificial Membrane Permeability Assay and Franz Cell Diffusion Assay

Open the PDF for in another window

Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference

Subject Area: General Medicine , Pharmacology , Public Health

Nicole E. Smolinski; Ruba Sajdeya; Robert Cook; Yan Wang; Almut G. Winterstein; Amie Goodin

Med Cannabis Cannabinoids (2022) 5 (1): 138–141. https://doi.org/10.1159/000527080

Abstract

View articletitled, Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference

Open the PDF for in another window

Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference (CCORC) Orlando, FL, USA, May 19-20, 2022

Subject Area: General Medicine , Pharmacology , Public Health

Med Cannabis Cannabinoids (2022) 5 (1): 142–158. https://doi.org/10.1159/000527081

View articletitled, Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference (CCORC) Orlando, FL, USA, May 19-20, 2022

Open the PDF for in another window

Cannabinoid Conference 2022

Subject Area: General Medicine , Pharmacology , Public Health

Med Cannabis Cannabinoids (2022) 5 (1): 159–198. https://doi.org/10.1159/000527113

View articletitled, Cannabinoid Conference 2022

Open the PDF for in another window

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects

Subject Area: General Medicine , Pharmacology , Public Health

John S. Markowitz; Ludmila De Faria; Qingchen Zhang; Philip W. Melchert; Reginald F. Frye; Brandon O. Klee; Yuli Qian

Med Cannabis Cannabinoids (2022) 5 (1): 199–206. https://doi.org/10.1159/000527189

Abstract

View articletitled, The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects

Open the PDF for in another window

Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?

Subject Area: General Medicine , Pharmacology , Public Health

Milena de Barros Viana; Pedro Everson Alexandre de Aquino; Débora Estadella; Daniel Araki Ribeiro; Glauce Socorro de Barros Viana

Med Cannabis Cannabinoids (2022) 5 (1): 207–219. https://doi.org/10.1159/000527335

Abstract

View articletitled, Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?

Open the PDF for in another window

Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder

Subject Area: General Medicine , Pharmacology , Public Health

Tobias Romeyke; Rudolf Westfal

Med Cannabis Cannabinoids (2022) 5 (1): 220–225. https://doi.org/10.1159/000527521

Abstract

View articletitled, Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder

Open the PDF for in another window